Charlie Zhou: Exploring the Potential of Immune Reset Therapies in Autoimmune Cytopenias
Charlie Zhou, Head of Portfolio Strategy at Ouro Medicines, shared a post on LinkedIn about the recent article he and his colleagues co-authored, adding:
“It’s been a privilege to collaborate with some of the preeminent experts in autoimmune cytopenias on this review examining the potential of immune reset therapies to change the treatment landscape for these debilitating conditions.”
Title: Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies
Authors: David J. Kuter, Sigbjørn Berentsen, Nichola Cooper, Lei Zhang, Jun Shi, Yunfei Chen, Lele Zhang, Charlie Zhou, Yanrong Wang, Jaideep S. Dudani, Neelufar Mozaffarian
Read the Full Article on Blood Reviews
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event